Contact: Jules Abraham
JQA Partners
917-885-7378
jabraham@jqapartners.com
MADISON, Wis. — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the Biotech Showcase in San Francisco on January 12, 2016 at 5:00 PM PT in the Mission I room.
“The Biotech Showcase is an important industry gathering, uniting a unique combination of established and emerging company participants with a diverse group of investors,” said Mr. Caruso. “With our recent announcements regarding the successful advancement of our multiple myeloma program and initial corporate collaboration to research a series of chemotherapeutics in combination with our PDC delivery platform, we welcome the opportunity for Cellectar to further update the investment community on our continued progress.”
Following the presentation, a link to the latest presentation, including both slides and audio, will be posted on the company’s website.
